Exploiting Race in Drug Development: BiDil's Interim Model of Pharmacogenomics

This paper explores events surrounding the US Food and Drug Administration's formal approval of the heart failure drug BiDil in 2005. BiDil is the first drug ever to be approved with a race-specific indication, in this case to treat heart failure in 'self-identified black patients'. B...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Social Studies of Science. - Sage Publications, Ltd.. - 38(2008), 5, Seite 737-758
1. Verfasser:	Kahn, Jonathan (VerfasserIn)
Format:	Online-Aufsatz
Sprache:	English
Veröffentlicht:	2008
Zugriff auf das übergeordnete Werk:	Social Studies of Science
Schlagworte:	Discrimination Ethnicity FDA Genetics Intellectual property Patents Pharmacogenomics Race Regulation Statistics mehr... Health sciences Behavioral sciences Applied sciences Biological sciences Law Philosophy